InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: ORBAPU post# 391845

Thursday, 10/27/2022 7:08:00 AM

Thursday, October 27, 2022 7:08:00 AM

Post# of 426487
The V.A. is funding Brave to see whether Vascepa affords PRIMARY PREVENTION of AD in a population with a "PARENTAL HISTORY of AD"...Upon a successful completion of the Brave study in these Vets who are predisposed to to have AD(due to their parental history), the FDA will IMO give approval for Vascepa Rx for AD...on the condition that the study be continued...A BP can then buy Amarin and supply the necessary funds to continue the larger study at the University of Wisconsin.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News